TY - JOUR
T1 - Usefulness of fluorine-18 fluorodeoxyglucose PET/computed tomography in diagnosis of aortitis and treatment response evaluation in a patient with aortic prosthesis
AU - Treglia, Giorgio
AU - Maggi, Fabio
AU - Bonomo, Lorenzo
AU - Giordano, Alessandro
PY - 2011
Y1 - 2011
N2 - We report the case of an 82-year-old man with aortic prosthesis inflammation in whom fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography has been useful in the detection of the cause of fever of unknown origin. We also describe the correlation between decrease of FDG uptake in the vascular prosthesis after treatment and clinical improvement with normalization of the serological levels of inflammatory markers.
AB - We report the case of an 82-year-old man with aortic prosthesis inflammation in whom fluorine-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography has been useful in the detection of the cause of fever of unknown origin. We also describe the correlation between decrease of FDG uptake in the vascular prosthesis after treatment and clinical improvement with normalization of the serological levels of inflammatory markers.
KW - Aged, 80 and over
KW - Anti-Bacterial Agents
KW - Aortic Aneurysm, Abdominal
KW - Aortitis
KW - Blood Vessel Prosthesis
KW - Blood Vessel Prosthesis Implantation
KW - Fever of Unknown Origin
KW - Fluorodeoxyglucose F18
KW - Humans
KW - Male
KW - Polyethylene Terephthalates
KW - Positron-Emission Tomography and Computed Tomography
KW - Predictive Value of Tests
KW - Prosthesis Design
KW - Radiopharmaceuticals
KW - Time Factors
KW - Treatment Outcome
KW - Aged, 80 and over
KW - Anti-Bacterial Agents
KW - Aortic Aneurysm, Abdominal
KW - Aortitis
KW - Blood Vessel Prosthesis
KW - Blood Vessel Prosthesis Implantation
KW - Fever of Unknown Origin
KW - Fluorodeoxyglucose F18
KW - Humans
KW - Male
KW - Polyethylene Terephthalates
KW - Positron-Emission Tomography and Computed Tomography
KW - Predictive Value of Tests
KW - Prosthesis Design
KW - Radiopharmaceuticals
KW - Time Factors
KW - Treatment Outcome
UR - http://hdl.handle.net/10807/25972
U2 - 10.2459/JCM.0b013e32834ba0fd
DO - 10.2459/JCM.0b013e32834ba0fd
M3 - Article
SN - 1558-2035
VL - 12
SP - 814
EP - 816
JO - Journal of Cardiovascular Medicine
JF - Journal of Cardiovascular Medicine
ER -